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Abstract
Bioceramic nanoparticles with high specific surface area often tend to agglomerate in the
polymer matrix, which results in undesirable mechanical properties of the composites and
poor cell spreading and attachment. In the present work, bredigite (BR) nanoparticles were
modified with an organosilane coupling agent, 3-glycidoxypropyltrimethoxysilane
(GPTMS), to enhance its dispersibility in the polymer matrix. The polyhydroxybutyrate-
co-hydroxyvaletare (PHBV) nanofibrous scaffolds containing either bredigite or GPTMS-
modified bredigite (G-BR) nanoparticles were fabricated using electrospinning technique
and characterized using scanning electron microscopy, transmission electron microscopy,
and tensile strength. Results demonstrated that modification of bredigite was effective in
enhancing nanoparticle dispersion in the PHBV matrix. PHBV/G-BR scaffold showed
improved mechanical properties compared to PHBV and PHBV/BR, especially at the
higher concentration of nanoparticles. In vitro bioactivity assay performed in the simulated
body fluid (SBF) indicated that composite PHBV scaffolds were able to induce the
formation of apatite deposits after incubation in SBF. From the results of in vitro biolog-
ical assay, it is concluded that the synergetic effect of BR and GPTMS provided an
enhanced hFob cells attachment and proliferation. The developed PHBV/G-BR
nanofibrous scaffolds may be considered for application in bone tissue engineering.
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Introduction
The native bone tissue extracellular matrix (ECM) is mainly composed of carbonated apatite
nanocrystals (2–5 nm wide and 70 nm long) and collagen type I fibrous matrix (50–500-nm
diameter) [1–3]. Considering the structural features of bone ECM, nanofibrous materials contain-
ing bioceramic nanoparticles can be served as ideal scaffolding materials for promoting osteoblast
proliferation and infiltration in bone tissue engineering applications. Till date, different methods
such as drawing, thermally induced phase separation, molecular self-assembly, and
electrospinning have been introduced and studied to produce nanofibers. Among them,
electrospinning is the most widely applied technique for generating nanoparticles embedded
nanofibrous scaffolds due to its ease of use and relatively low-cost instrumental setup [4–6].
Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), amember of the polyhydroxyalkanoates
family, is the copolymer of polyhydroxybutyrate and polyhydroxyvalerate which has been reported to
promote bone growth in vivo, because of its piezoelectric properties. In addition, it decomposes to 3-
hydroxybutyric acid, a normal constituent of blood which increases calcium influx to the cells and
prevents cells death. This makes the polymer highly biocompatible and non-toxic for application as
scaffolding materials for bone tissue engineering applications [7–9].
Previous studies have demonstrated that Mg-Ca-Si-based bioceramics possessed superior
apatite-mineralization ability, biocompatibility, and biological properties compared to calcium
phosphate bioceramics. Bredigite (Ca7MgSi4O16) is belonging to this category which is found to
have great cytocompatibility, a highly stimulating effect on osteoblast proliferation and osteogenic
differentiation potential [10–13]. In our previous work, bredigite nanoparticles were synthesized
using the sol–gel method and incorporated into PHBV nanofibers through electrospinning. Our
results revealed that addition of bredigite nanoparticles more than 10% resulted in the production
of uneven nanofibers with reduced mechanical properties due to the particle agglomeration [4,
14]. When hydrophilic nanoparticles are applied in combination with hydrophobic polymers, a
main problem usually emerged, that is the inhomogeneous dispersion of the nanoparticles in the
matrix. Nano-size particles with an enormous surface area and high surface energy tend to
agglomerate in polymer matrix due to the weak interface between the nanoparticles and polymer
matrix. This aggregation and incompatibility would become the origin of the early failure, which
decreases the mechanical performance of the composites and prevents cell attachment/
proliferation and protein adsorption [15–17]. To improve the compatibility and dispersibility of
inorganic nanoparticles, different organic modifiers, such as cetyl trimethylammonium bromide
[18], polyethylene glycol [19], dodecyl alcohol [20], and stearic acid [21], were applied and
investigated. However, these modifiers exhibited some disadvantages such as weak binding to the
nanoparticles, reduction in the hydrophilicity, and having cytotoxicity effect, which make them
unsuitable for preparing tissue engineering scaffolds [16, 17]. In the present study, we utilized 3-
glycidoxypropyltrimethoxysilane (GPTMS) as a coupling agent to improve the dispersion of
bredigite nanoparticles within the PHBV matrix. In a study by Li et al. [22], the pretreating of
hydroxyapatite nanoparticles with GPTMS was reported. Their results showed improved nano-
particle dispersion in polycaprolactone matrix. It was also demonstrated that mechanical proper-
ties and bioactivity of the scaffolds were highly improved by applying modified nanoparticles.
In the current research work, bredigite nanoparticles were modified with GPTMS and
loaded into PHBV nanofibers using electrospinning. Resultant PHBV nanofiberrous scaffolds
were characterized and their mechanical properties and apatite-forming ability were evaluated.
Finally, hFob cells were cultured on the composite scaffolds to assay cell–scaffold interaction
for bone tissue engineering applications.
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Materials and Methods
Surface Modification of Bredigite Nanoparticles
Bredigite (BR) nanoparticles obtained from our previous work [23] were mixed with
GPTMS (Sigma–Aldrich) solution in ethanol (1:50 v/v) followed by a stirring at 60 °C for
2 h. The temperature was then raised up to 75 °C to evaporate ethanol and the GPTMS-
modified bredigite (G-BR) nanoparticles were dried for 24 h at 120 °C under vacuum. The
modification process is schematically given in Fig. 1. To investigate the chemical composi-
tion of BR and G-BR nanoparticles, Fourier transform infrared (FTIR) spectrometer (Avatar
380 - ThermoQ14 Nicolet, MA) was utilized at a resolution of 4 cm−1 and a spectra range of
4000–400 cm−1.
Electrospinning of Composite Nanofibers
Electrospun PHBV/BR and PHBV/G-BR nanofibers were developed according to our previ-
ous study [4]. Briefly, the desired amount of BR and G-BR nanoparticles was sonicated in
1,1,1,3,3,3 hexafluoro-2-propanol (Sigma) for 30 min, and then PHBV (HV content 3%, Mw:
400000, TianAn Enmat Chemical Company, China) was added to the obtained mixture to get a
8 wt% polymer solution, and stirred at room temperature overnight. The prepared solutions
were subjected to an electrospinning setup made of a high voltage (Gamma High Voltage
Research, FL, USA), a syringe pump (KD 100 Scientific Inc., Holliston, MA, USA), and a
collector. Electrospinning was performed at the flow rate of 1 ml/h, a high voltage of 14 kV,
and working distance of 18 cm. The produced nanofibers were dried at room temperature for
24 h and kept in desiccator for further tests.
Morphological Characterization of the Nanofibers
Field emission scanning microscopy (FESEM: HITACHI S-4300, Japan) was employed to
observe and study the morphology of electrospun nanofiber. The diameter of the obtained
nanofiber was determined from FESEM images using ImageJ software (Image Java, National
Institutes of Health, Bethesda, MD, USA). Transmission electron microscopy (TEM, Philips
CM-120) was used to observe the nanoparticle distribution and agglomeration within the
composite nanofiber.
Fig. 1 Schematic of surface modification of bredigite nanoparticles
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Mechanical Characterization of the Nanofibrous Scaffolds
For the mechanical characterization of the nanofibrous scaffolds, rectangular strips (10 ×
20 mm2) of the scaffolds were mounted vertically on the gripping unit of a tabletop tensile
tester (Instron 5943, USA) and tested with a load cell of 50 N at a crosshead of 10 mm/min.
Tensile properties of the samples including tensile strength, Young modulus, and elongation at
break were calculated from the stress–strain curves. The test was repeated five times for each
specimen and the data was reported as the mean and standard deviation.
In Vitro Bioactivity Evaluation
Bone-like apatite-forming ability of the nanofibrous scaffolds was examined by immersion the
samples into the simulated body fluid (SBF) solution with the ion concentration similar to
those of the human body. Nanofibrous scaffolds of 10 × 10 mm2 were soaked in 30 ml of SBF
solution in polyethylene bottle at 37 °C and pH of 7.4 for the predetermined time period and
then were washed with DI water, dried and subjected to SEM coupled with energy dispersive
spectroscopy (SEM–EDS) for further characterization. The formation of apatite layer on the
surface of composite nanofibrous scaffolds was confirmed by X-ray diffractometer (XRD)
(Philips X’Pert-MPD, Cu Ka radiation at 30 mA and 40 kV, at a scan rate of 3°/min). Ion
concentration of the SBF solution during bioactivity test was determined using inductively
coupled plasma atomic emission spectroscopy (ICP-OES, Perkin-Elmer Optima 7300DV).
In Vitro Cellular Assay
Cell Culture
The hFob cells, obtained from the American Type Culture Collection (ATCC, VA 20108,
USA), were cultured in Dulbecco’s modified eagles medium/nutrient mixture F-12
(DMEM/F12, Sigma–Aldrich, Singapore), supplemented with 10% fetal bovine serum
(FBS, GIBCO, Invitrogen Corp, USA) and 1% antibiotic solution (Sigma–Aldrich, A5955),
and incubated in CO2 incubator at 37 °C and 5% CO2. After confluency, cells were detached
by trypsin/EDTA (GIBCO, Invitrogen Corp, USA) and seeded on the nanofibrous scaffolds at
the seeding density of 10,000 cells/well. To study cell–scaffold interactions, the nanofibrous
scaffolds were placed in a 24-well plate and pressed with stainless steel rings. The scaffolds
were then sterilized using UV light for 2 h, washed three times with PBS, and immersed in
complete medium (DMEM/F12-10% FBS-1% antibiotics) overnight before culturing of cells.
Cell Proliferation
The hFob proliferation on the electrospun scaffolds was evaluated using the colorimetric MTS
assay (CellTiter 96 Aqueous One solution; Promega, Madison, USA) at 490 nm. After 5, 10,
and 15 days of cell culture, the media was discarded from the wells and the scaffolds were
rinsed with PBS and incubated with MTS reagent (20%) in serum-free medium in 5% CO2
incubator at 37 °C for 3 h. After the incubation period, the obtained dye was aliquoted into 96-
well plates and read using a spectrophotometric plate reader (FLUO star OPTIMA, BMG Lab
Technologies, Germany). The experiments were repeated three times and the cells grown on
tissue culture plastic (TCP) served as the control.
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Cell Morphology Study
The morphology of the hFob cells cultured on the different samples was evaluated using
FESEM. After 5 and 15 days of the cell culture, the media was discarded from the wells and
the samples were rinsed with PBS and fixed with glutaraldehyde in PBS (3%) for 3 h. The
scaffolds with cells were then rinsed with distilled water for 15 min and dehydrated with a
series of ethanol solutions of increasing concentrations (30%, 50%, 75%, 90%, and 100% (v/
v)), finally treated with hexamethyldisilazane (HMDS, Sigma–Aldrich), and left to dry
overnight at ambient temperature. The dried samples were observed under FESEM.
Statistical Analysis
All data are shown as means and standard deviation. Statistical significance was evaluated
using a one-way analysis of variance (ANOVA) with pairwise comparisons made by Tukey’s
post hoc analysis. The significant differences were indicated at P < 0.05.
Results and Discussion
Characterization of Nanoparticles and Nanofibrous Scaffolds
Figure 2a, b shows the SEM and TEM images of BR nanoparticles which appear to be irregular
particles with size ranging from 25 to 50 nm that tend to agglomerate. The successful modification
of BR nanoparticles with GPTMS was confirmed by FTIR spectroscopy. Figure 2c shows the
FTIR spectra of BR and G-BR nanoparticles. The spectra for BR nanoparticles show the
characteristics peaks of bredigite including SiO4 stretching bond at 1000–1100 cm−1 and
869 cm−1, SiO4 bending bond at 620 cm−1 and 460 cm−1, Mg–O bond at 475 cm−1, and Ca–O
stretching bond at 533 cm−1 [23, 24]. On modification with GPTMS, the peaks at 911 cm−1 and
1090 cm−1 corresponding to the epoxy group and Si–OCH3 bond, respectively, were appeared or
their intensity increased, confirming the presence of GPTMS on the surface of bredigite [25–27].
Figure 3 shows the SEM images of the pure PHBVand PHBVnanofibers containing 5% and 15%
of either BR or G-BR nanoparticles. The mean fiber diameter of the pure and composite PHBV
nanofibers is given in Table 1. Continuous and relatively even nanofibers were successfully
obtained for pure PHBVand composite PHBV nanofibers containing 5% of either BR or G-BR
Fig. 2 SEM image of BR nanoparticles (a), TEM image of BR nanoparticles (b), and FTIR spectra of BR and G-
BR nanoparticles (c)
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nanoparticles. A slight increase in mean fiber diameter was observed by incorporation of
nanoparticles. By increasing the concentration of BR nanoparticles to 15%, a sign of agglomer-
ation was observed for BR nanoparticles embedded nanofiber; however, PHBV composite
nanofibers containing 15% G-BR nanoparticles showed the relatively better dispersion of nano-
particles as a result of GPTMS modification. This observation was then confirmed by TEM
analysis as given in Fig. 3. TEM images show that G-BR nanoparticles dispersed more homog-
enous than BR nanoparticles within PHBV nanofibers.
The mechanical performance of the nanofibrous structures incorporated with nanoparticles is
highly affected by the particle dispersion state. The mechanical properties of PHBV nanofibrous
scaffolds were evaluated by their Young’s modulus, ultimate strength, and strain at break. Figure 4
shows the stress–strain curves for PHBV, PHBV/5%BR, PHBV/15%BR, PHBV/5%G-BR, and
PHBV/15%G-BR scaffolds, along with the mechanical properties of different scaffolds. Young’s
modulus, ultimate strength, and strain at break of the nanofibrous samples are summarized in
Table 1. All stress–strain curves exhibited a similar trend with remarkable changes in mechanical
properties depending on bredigite concentration and its dispersion state within the PHBV scaffolds.
As evident from the results, by incorporation of 5% nanoparticles, Young’s modulus and ultimate
strength of PHBV scaffolds (106.7MPa and 4.41MPa, respectively) were significantly increased to
147.3 MPa and 4.9 MPa for PHBV/5%BR, and to 150.1 MPa and 5.2 MPa for PHBV/5%G-BR,
Fig. 3 SEM images of pure PHBV (a), PHBV/5%BR (c), PHBV/5%G-BR (d), PHBV/15%BR (red circles
indicate the nanoparticles’ agglomerates) (e), and PHBV/15%G-BR (g) nanofibrous scaffolds and TEM images
of pure PHBV (b), PHBV/15%BR (f), and PHBV/15%G-BR (h) nanofibers
Table 1 Average fiber diameter and the mechanical properties of different nanofibrous scaffolds
Average fiber
diameter (nm)
Young’s
modulus (MPa)
Ultimate
strength (MPa)
Elongation at
break (%)
PHBV 359 ± 30 106.7 ± 31.3 4.41 ± 0.27 64.61 ± 22.78
PHBV/5%BR 378 ± 19 147.3 ± 33.2 4.96 ± 0.69 54.49 ± 7.78
PHBV/5%G-BR 389 ± 24 150.1 ± 10.1 5.20 ± 0.49 58.61 ± 10.24
PHBV/15%BR 361 ± 73 105.6 ± 34.6 3.87 ± 0.38 39.83 ± 11.38
PHBV/15%G-BR 393 ± 14 175 ± 25.6 6.36 ± 0.54 60.76 ± 5.21
PHBV/20%G-BR 397 ± 85 183.4 ± 41.1 6.52 ± 0.21 57.26 ± 15.3
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due to reinforcement effect of nanoparticles; however, elongation at break decreased from64.6% for
PHBV scaffold to 54.5% (PHBV/5%BR) and 58.6% (PHBV/5%G-BR), indicating higher resis-
tance to deformation. This behavior can be attributed to the bredigite stiffness which decreased the
flexibility of the PHBV composite scaffolds. According to Fig. 4, at higher concentration of
nanoparticles (15%), the PHBV/15%BR scaffolds exhibited lower Young’s modulus and ultimate
strength compared to all other PHBV scaffolds, because of the nanoparticle agglomeration and
concentrated stress on the agglomerates. Such a reduction in the mechanical properties of the
composite nanofibrous structures by increasing the particle concentration has been reported
previously in the literature [22, 28]. By incorporation of 15% G-BR nanoparticles, strength and
modulus of PHBV composite scaffold was significantly increased compared to pure PHBV and
PHBV/15%BR scaffolds (P ≤ 0.05), due to the better dispersion of the G-BR nanoparticles within
PHBV matrix which allows better transference of concentrated stress from the matrix to nanopar-
ticles. These findings suggest that GPTMS treatment is beneficial in improving the mechanical
performance of PHBV composite scaffolds at higher concentration of nanoparticles.
In Vitro Bioactivity Evaluation
In vitro bone-like mineral-forming ability at the material surface is thought to be an important
property of scaffolds for bone tissue engineering applications, which were examined by immersion
test in SBF during this research. Figure 5 shows the morphological changes of the pure and
composite PHBV scaffolds containing 15% either BR or G-BR nanoparticles after incubation for
2 and 4 weeks. After 2-week incubation in SBF, the formation of apatite mineral deposits on the
PHBV nanofibers containing nanoparticles was evidence which was grown to the flower-like
structures and covered the entire surface of the nanofibers at prolonged incubation time (4 weeks),
while pure PHBV nanofibers did not induce the formation of apatite minerals after 4 weeks. As
reported in the literature, ceramic and glass-ceramic biomaterials containing CaO–SiO2 can induce
apatite nucleation and growth through the formed silanol group (Si–OH) as a result of Si–O–Si
bonds breakage [4]. Morphological features of the formed deposits on PHBV/BR and PHBV/G-BR
Fig. 4 Stress–strain curves of pure and composite PHBV nanofibrous scaffolds (a), and mechanical properties of
the PHBV nanofibrous scaffolds, Young’s modulus (b), ultimate strength (c), and strain at break (d) (*significant
difference between the group at P < 0.05)
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nanofiber surfaces were similar, indicating that scaffolds remained still bioactive after surface
modificationwithGPTMS. Figure 6 shows the results of EDS analysis on the surface of nanofibrous
scaffolds after 4 weeks incubation in SBF. According to the EDS results, the newly formedmaterials
are mainly composed of calcium and phosphorous, which were further characterized by XRD
analysis (Fig. 7). In theXRDpattern of all samples, several diffraction peaks at around 14, 17, 20, 22,
and 27.5 degrees can be observed which could be assigned to the crystalline structure of PHBV [29,
30]. In theXRDpattern of PHBV/BR and PHBV/G-BR, the presence of two peaks at around 26 and
32 degrees confirmed the formation of crystalline apatite on the surface of composite nanofibers after
incubation in SBF. The results of EDS and XRD analysis together with the SEM observation
revealed that PHBV nanofibrous scaffolds incorporated with either BR or G-BR nanoparticles have
the ability to produce bone-like apatite layer on their surface during incubation in SBF.
Figure 8 shows the changes in silicon (Si), calcium (Ca), and phosphorous (P) ion concentra-
tion in SBF containing composite PHBV nanofibers after 4-week incubation of samples, which
was determined by ICP analysis. Results showed that Si concentrations in SBF increased with
Fig. 5 SEM images of PHBV, PHBV/BR, and PHBV/G-BR nanofibrous scaffolds after 2- and 4-week
incubation in SBF
Fig. 6 EDS analysis of the surface of nanofibrous scaffolds after incubation in SBF for 4 weeks: a PHBV, b
PHBV/BR, and c PHBV/G-BR
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increasing soaking time, which was attributed to the dissolution of the Si ion from the bredigite.
The concentration of P ion in SBF decreased during incubation, due to the P consumption from
the SBF solution toward the surface of the samples to form and growth of apatite deposits. The
trend in Ca concentration showed an increase in the beginning due to the dissolution of the Ca into
the SBF, followed by a decrease during immersion test, due to the formation of Ca-P layer on the
surface of the samples. The formation and growth of Ca-P nuclei cause the formation of apatite
layer which consumes the Ca and P ions from the surrounding liquid [31, 32], resulting in the
observed decrease in Ca and P concentration in SBF solution. Compared to BR nanoparticles, G-
BR nanoparticles embedded nanofibers consumed more Ca and P ions from the solution which
might be due to the presence of silanol groups on the surface of modified nanoparticles, which
increased nucleation sites for the formation of apatite minerals [3].
In Vitro Cellular Assay
The proliferation of hFob cells on the different scaffolds was evaluated using colorimetric MTS
assay. Figure 9 shows the results of MTS assay on different nanofibrous scaffolds and control
sample, which demonstrated that all samples got the upward trend, indicating that cells grew on the
surface of all substrates. The hFob cultured on pure PHBV scaffold showed the lower proliferation
compared to composite PHBV scaffolds and TCP. Biomaterials with hydrophobic nature exhibit a
lower cell adhesion and proliferation [33]. By incorporating either BR or G-BR nanoparticles into
PHBV nanofibers, the proliferation of hFob cells enhanced by 22% and 35%, respectively, after
5 days of cell culture. As reported in the previous studies, silicate-based bioceramics could stimulate
Fig. 7 XRD patterns of different samples after incubation in SBF for 4 weeks: (a) PHBV, (b) PHBV/BR, and (c)
PHBV/G-BR
Fig. 8 The changes in Si, P, and Ca ion concentrations in SBF solution during incubation of the scaffolds for 4 weeks
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the osteoblasts cell adhesion, spreading and proliferation through releasing the Si-containing ionic
products [34, 35]. Results of cell proliferation study also demonstrated that PHBV/G-BR scaffolds
presented significantly higher hFob proliferation than PHBV/BR scaffolds by 27% and 33% after 10
and 15 days of cell culture, respectively. It has been reported that Si–OH and –Si–O–Si–groups of
GPTSMhave an important effect on osteoblast proliferation since Si ions are known to influence the
activity of bone cells [36]. Therefore, it is concluded that the synergetic effect of BR and GPTMS
provided an enhanced cell attachment and growth.
Cellular morphology of the hFob cells seeded on PHBV, PHBV/BR, PHBV/G-BR, and control
sampleswere visualized by FESEM (Fig. 10) after 5 and 15 days of cell seeding. On day 5, the hFob
cells tethered to the surface of all nanofibrous scaffolds with flattened and polygonal extensions;
however, the cells apparently spread and grew better on composite PHBV scaffolds compared to
pure PHBV and control sample. After 15 days of cell culture, the surface of PHBV composite
scaffolds was completely covered by a thick layer of cells with the formation of mineral deposits
revealing the confluent cell growth and cell-secreted mineralization. Overall results demonstrated
that incorporation of G-BR nanoparticles instead of BR nanoparticles into the PHBV nanofibrous
scaffolds enabled them to possess better microarchitecture as a result of better dispersibility,
improved mechanical properties, and enhanced biological performance.
Fig. 9 Proliferation of hFob cells determined by MTS assay on PHBV, PHBV/BR, and PHBV/G-BR
nanofibrous scaffolds and TCP on days 5, 10, and 15 (*significant difference relative to PHBV scaffold
(P < 0.05), £: significant difference relative to PHBV/BR scaffold (P < 0.05))
100 µm 
a)
h) g)f)e)
d)c)b)
100 µm 100 µm 100 µm 100 µm 
100 µm 100 µm 100 µm 
Fig. 10 SEM images of hFob cells cultured on TCP (a, e), PHBV (b, f), PHBV/BR (c, g), and PHBV/G-BR (d,
i) scaffolds on days 5 (a–d) and 15 (e–h), representing the cell growth and mineralization
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Conclusion
In this research, bredigite nanoparticles were modified with GPTMS and incorporated into PHBV
nanofibers through electrospinning technique. On modification with GPTMS, the better dispersion
state of BR nanoparticles within the PHBVmatrix was obtained, which resulted in the production of
composite nanofibers with homogenous and even structures. Incorporation of modified BR nano-
particles significantly improved the strength andmodulus of PHBV composite scaffold compared to
pure PHBV and PHBV containing unmodified BR, especially at the higher concentration of
nanoparticles. The fabricated PHBV/G-BR nanofibrous scaffold was in vitro bioactive, the apatite
deposits were observed on the fiber surface after soaking in SBF. Moreover, the in vitro cellular
assay revealed that PHBV/G-BR scaffold exhibited enhanced hFob cell attachment and proliferation
compared to PHBV/BR, suggesting its greater potential for bone tissue engineering application.
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